25 XP   0   0   10

Henan Lingrui Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Lingrui together

PenkeI guess you are interested in Henan Lingrui Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Henan Lingrui Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Henan Lingrui Pharmaceutical Co Ltd

I send you an email if I find something interesting about Henan Lingrui Pharmaceutical Co Ltd.

Quick analysis of Lingrui (30 sec.)










What can you expect buying and holding a share of Lingrui? (30 sec.)

How much money do you get?

How much money do you get?
¥0.28
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥4.51
Expected worth in 1 year
¥6.43
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥3.96
Return On Investment
15.7%

For what price can you sell your share?

Current Price per Share
¥25.30
Expected price per share
¥20.53 - ¥
How sure are you?
50%

1. Valuation of Lingrui (5 min.)




Live pricePrice per Share (EOD)

¥25.30

Intrinsic Value Per Share

¥9.10 - ¥24.86

Total Value Per Share

¥13.60 - ¥29.37

2. Growth of Lingrui (5 min.)




Is Lingrui growing?

Current yearPrevious yearGrowGrow %
How rich?$353m$315.5m$37.5m10.6%

How much money is Lingrui making?

Current yearPrevious yearGrowGrow %
Making money$64.2m$49.8m$14.3m22.3%
Net Profit Margin15.5%13.4%--

How much money comes from the company's main activities?

3. Financial Health of Lingrui (5 min.)




What can you expect buying and holding a share of Lingrui? (5 min.)

Welcome investor! Lingrui's management wants to use your money to grow the business. In return you get a share of Lingrui.

What can you expect buying and holding a share of Lingrui?

First you should know what it really means to hold a share of Lingrui. And how you can make/lose money.

Speculation

The Price per Share of Lingrui is ¥25.30. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lingrui.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lingrui, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.51. Based on the TTM, the Book Value Change Per Share is ¥0.48 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.51 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lingrui.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.110.4%0.110.4%0.090.3%0.080.3%0.060.2%
Usd Book Value Change Per Share0.070.3%0.070.3%-0.010.0%0.020.1%0.050.2%
Usd Dividend Per Share0.070.3%0.070.3%0.050.2%0.040.2%0.030.1%
Usd Total Gains Per Share0.140.5%0.140.5%0.050.2%0.070.3%0.070.3%
Usd Price Per Share1.80-1.80-2.18-1.51-1.49-
Price to Earnings Ratio15.90-15.90-24.81-18.54-31.00-
Price-to-Total Gains Ratio13.17-13.17-47.60-69.45-47.88-
Price to Book Ratio2.89-2.89-3.92-2.70-3.23-
Price-to-Total Gains Ratio13.17-13.17-47.60-69.45-47.88-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.4914
Number of shares286
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.070.04
Usd Book Value Change Per Share0.070.02
Usd Total Gains Per Share0.140.07
Gains per Quarter (286 shares)39.0818.62
Gains per Year (286 shares)156.3474.49
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
18076146502564
21611523029950138
324122845814975212
432130461419899286
5402380770248124360
6482456926298149434
75635321082347174508
86436081238397199582
97236841394447224656
108047601550496249730

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%7.03.00.070.0%17.06.00.073.9%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%22.00.01.095.7%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%22.01.00.095.7%

Fundamentals of Lingrui

About Henan Lingrui Pharmaceutical Co Ltd

Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering various product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is based in Xinyang, China.

Fundamental data was last updated by Penke on 2024-04-17 06:33:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Henan Lingrui Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Lingrui earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Lingrui to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 15.5% means that ¥0.16 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 15.5%. The company is making a huge profit. +2
  • The TTM is 15.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ15.5%TTM15.5%0.0%
TTM15.5%YOY13.4%+2.1%
TTM15.5%5Y13.7%+1.8%
5Y13.7%10Y14.1%-0.4%
1.1.2. Return on Assets

Shows how efficient Lingrui is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lingrui to the Drug Manufacturers - Specialty & Generic industry mean.
  • 10.7% Return on Assets means that Lingrui generated ¥0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 10.7%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 10.7%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ10.7%TTM10.7%0.0%
TTM10.7%YOY9.5%+1.2%
TTM10.7%5Y9.3%+1.4%
5Y9.3%10Y7.9%+1.4%
1.1.3. Return on Equity

Shows how efficient Lingrui is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lingrui to the Drug Manufacturers - Specialty & Generic industry mean.
  • 18.2% Return on Equity means Lingrui generated ¥0.18 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 18.2%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 18.2%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ18.2%TTM18.2%0.0%
TTM18.2%YOY15.9%+2.4%
TTM18.2%5Y14.6%+3.6%
5Y14.6%10Y12.3%+2.3%

1.2. Operating Efficiency of Henan Lingrui Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Lingrui is operating .

  • Measures how much profit Lingrui makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lingrui to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY14.0%-14.0%
TTM-5Y11.4%-11.4%
5Y11.4%10Y11.5%-0.1%
1.2.2. Operating Ratio

Measures how efficient Lingrui is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.13 means that the operating costs are ¥1.13 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 1.134. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.134. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.134TTM1.1340.000
TTM1.134YOY1.107+0.027
TTM1.1345Y1.096+0.038
5Y1.09610Y0.981+0.114

1.3. Liquidity of Henan Lingrui Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Lingrui is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.47 means the company has ¥1.47 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 1.465. The company is just able to pay all its short-term debts.
  • The TTM is 1.465. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.465TTM1.4650.000
TTM1.465YOY1.482-0.017
TTM1.4655Y1.634-0.168
5Y1.63410Y1.292+0.341
1.3.2. Quick Ratio

Measures if Lingrui is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lingrui to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.20 means the company can pay off ¥0.20 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 0.202. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.202. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.202TTM0.2020.000
TTM0.202YOY0.315-0.113
TTM0.2025Y0.400-0.198
5Y0.40010Y0.388+0.012

1.4. Solvency of Henan Lingrui Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Lingrui assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lingrui to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.41 means that Lingrui assets are financed with 41.1% credit (debt) and the remaining percentage (100% - 41.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 0.411. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.411. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.411TTM0.4110.000
TTM0.411YOY0.397+0.014
TTM0.4115Y0.359+0.052
5Y0.35910Y0.357+0.001
1.4.2. Debt to Equity Ratio

Measures if Lingrui is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lingrui to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 70.0% means that company has ¥0.70 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 0.700. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.700. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.700TTM0.7000.000
TTM0.700YOY0.661+0.039
TTM0.7005Y0.567+0.133
5Y0.56710Y0.567+0.000

2. Market Valuation of Henan Lingrui Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Lingrui generates.

  • Above 15 is considered overpriced but always compare Lingrui to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 15.90 means the investor is paying ¥15.90 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The EOD is 30.853. Based on the earnings, the company is overpriced. -1
  • The MRQ is 15.902. Based on the earnings, the company is fair priced.
  • The TTM is 15.902. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD30.853MRQ15.902+14.951
MRQ15.902TTM15.9020.000
TTM15.902YOY24.812-8.910
TTM15.9025Y18.542-2.640
5Y18.54210Y31.000-12.458
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The EOD is 17.770. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 9.159. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 9.159. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD17.770MRQ9.159+8.611
MRQ9.159TTM9.1590.000
TTM9.159YOY11.669-2.510
TTM9.1595Y11.876-2.717
5Y11.87610Y11.063+0.813
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Lingrui is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The EOD is 5.611. Based on the equity, the company is overpriced. -1
  • The MRQ is 2.892. Based on the equity, the company is underpriced. +1
  • The TTM is 2.892. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD5.611MRQ2.892+2.719
MRQ2.892TTM2.8920.000
TTM2.892YOY3.923-1.031
TTM2.8925Y2.705+0.187
5Y2.70510Y3.233-0.529
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Henan Lingrui Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4810.4810%-0.062+113%0.158+206%0.328+47%
Book Value Per Share--4.5094.5090%4.027+12%4.022+12%3.512+28%
Current Ratio--1.4651.4650%1.482-1%1.634-10%1.292+13%
Debt To Asset Ratio--0.4110.4110%0.397+4%0.359+15%0.357+15%
Debt To Equity Ratio--0.7000.7000%0.661+6%0.567+23%0.567+24%
Dividend Per Share--0.5090.5090%0.394+29%0.314+62%0.214+138%
Eps--0.8200.8200%0.637+29%0.593+38%0.449+83%
Free Cash Flow Per Share--1.4241.4240%1.354+5%0.958+49%0.445+220%
Free Cash Flow To Equity Per Share--1.4241.4240%0.947+50%0.576+147%0.288+394%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--24.858--------
Intrinsic Value_10Y_min--9.096--------
Intrinsic Value_1Y_max--1.441--------
Intrinsic Value_1Y_min--0.569--------
Intrinsic Value_3Y_max--5.130--------
Intrinsic Value_3Y_min--2.016--------
Intrinsic Value_5Y_max--9.783--------
Intrinsic Value_5Y_min--3.788--------
Market Cap14348641190.400+48%7399665255.6807399665255.6800%8970592073.600-18%6242201206.016+19%6166807701.580+20%
Net Profit Margin--0.1550.1550%0.134+15%0.137+13%0.141+10%
Operating Margin----0%0.140-100%0.114-100%0.115-100%
Operating Ratio--1.1341.1340%1.107+2%1.096+3%0.981+16%
Pb Ratio5.611+48%2.8922.8920%3.923-26%2.705+7%3.233-11%
Pe Ratio30.853+48%15.90215.9020%24.812-36%18.542-14%31.000-49%
Price Per Share25.300+48%13.04013.0400%15.800-17%10.946+19%10.802+21%
Price To Free Cash Flow Ratio17.770+48%9.1599.1590%11.669-22%11.876-23%11.063-17%
Price To Total Gains Ratio25.549+48%13.16813.1680%47.602-72%69.448-81%47.882-72%
Quick Ratio--0.2020.2020%0.315-36%0.400-49%0.388-48%
Return On Assets--0.1070.1070%0.095+12%0.093+16%0.079+36%
Return On Equity--0.1820.1820%0.159+15%0.146+25%0.123+48%
Total Gains Per Share--0.9900.9900%0.332+198%0.472+110%0.542+83%
Usd Book Value--353068284.141353068284.1410%315547372.916+12%316906541.392+11%277225238.917+27%
Usd Book Value Change Per Share--0.0660.0660%-0.009+113%0.022+206%0.045+47%
Usd Book Value Per Share--0.6220.6220%0.556+12%0.555+12%0.485+28%
Usd Dividend Per Share--0.0700.0700%0.054+29%0.043+62%0.030+138%
Usd Eps--0.1130.1130%0.088+29%0.082+38%0.062+83%
Usd Free Cash Flow--111492387.209111492387.2090%106091536.661+5%75365364.191+48%34982106.207+219%
Usd Free Cash Flow Per Share--0.1960.1960%0.187+5%0.132+49%0.061+220%
Usd Free Cash Flow To Equity Per Share--0.1960.1960%0.131+50%0.079+147%0.040+394%
Usd Market Cap1980112484.275+48%1021153805.2841021153805.2840%1237941706.157-18%861423766.430+19%851019462.818+20%
Usd Price Per Share3.491+48%1.8001.8000%2.180-17%1.511+19%1.491+21%
Usd Profit--64215654.13464215654.1340%49892887.856+29%46645753.601+38%35416254.669+81%
Usd Revenue--414256985.529414256985.5290%371704506.724+11%337744395.015+23%250039179.089+66%
Usd Total Gains Per Share--0.1370.1370%0.046+198%0.065+110%0.075+83%
 EOD+4 -4MRQTTM+0 -0YOY+25 -105Y+26 -910Y+28 -7

3.2. Fundamental Score

Let's check the fundamental score of Henan Lingrui Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1530.853
Price to Book Ratio (EOD)Between0-15.611
Net Profit Margin (MRQ)Greater than00.155
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.202
Current Ratio (MRQ)Greater than11.465
Debt to Asset Ratio (MRQ)Less than10.411
Debt to Equity Ratio (MRQ)Less than10.700
Return on Equity (MRQ)Greater than0.150.182
Return on Assets (MRQ)Greater than0.050.107
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Henan Lingrui Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5074.325
Ma 20Greater thanMa 5022.415
Ma 50Greater thanMa 10021.126
Ma 100Greater thanMa 20019.110
OpenGreater thanClose24.450
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets4,344,383
Total Liabilities1,785,917
Total Stockholder Equity2,550,919
 As reported
Total Liabilities 1,785,917
Total Stockholder Equity+ 2,550,919
Total Assets = 4,344,383

Assets

Total Assets4,344,383
Total Current Assets2,508,393
Long-term Assets1,835,990
Total Current Assets
Cash And Cash Equivalents 1,179,296
Short-term Investments 150,421
Net Receivables 195,973
Inventory 486,411
Other Current Assets 131,851
Total Current Assets  (as reported)2,508,393
Total Current Assets  (calculated)2,143,953
+/- 364,440
Long-term Assets
Property Plant Equipment 706,764
Intangible Assets 241,868
Long-term Assets Other 366,560
Long-term Assets  (as reported)1,835,990
Long-term Assets  (calculated)1,315,192
+/- 520,798

Liabilities & Shareholders' Equity

Total Current Liabilities1,711,948
Long-term Liabilities73,968
Total Stockholder Equity2,550,919
Total Current Liabilities
Short Long Term Debt 93,811
Accounts payable 68,021
Other Current Liabilities 50,834
Total Current Liabilities  (as reported)1,711,948
Total Current Liabilities  (calculated)212,666
+/- 1,499,282
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt6,197
Long-term Liabilities  (as reported)73,968
Long-term Liabilities  (calculated)6,197
+/- 67,772
Total Stockholder Equity
Retained Earnings 1,380,683
Total Stockholder Equity (as reported)2,550,919
Total Stockholder Equity (calculated)1,380,683
+/- 1,170,236
Other
Capital Stock567,459
Common Stock Shares Outstanding 567,459
Net Invested Capital 2,644,730
Net Working Capital 796,444
Property Plant and Equipment Gross 1,227,758



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
514,794
560,377
697,745
741,336
828,814
872,235
878,693
942,551
968,269
1,024,204
1,198,939
1,208,031
1,294,324
1,648,124
2,474,453
2,832,731
2,981,521
3,307,565
3,109,964
3,315,778
3,457,756
3,793,087
4,344,383
4,344,3833,793,0873,457,7563,315,7783,109,9643,307,5652,981,5212,832,7312,474,4531,648,1241,294,3241,208,0311,198,9391,024,204968,269942,551878,693872,235828,814741,336697,745560,377514,794
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
963,843
1,562,833
1,616,980
1,594,808
1,754,361
1,916,541
2,131,237
2,508,393
2,508,3932,131,2371,916,5411,754,3611,594,8081,616,9801,562,833963,843000000000000000
       Cash And Cash Equivalents 
315,170
224,597
251,935
204,217
193,117
228,444
202,675
144,446
171,668
180,527
251,458
280,877
229,459
441,933
370,739
415,045
377,925
340,999
640,026
741,211
732,317
801,242
1,179,296
1,179,296801,242732,317741,211640,026340,999377,925415,045370,739441,933229,459280,877251,458180,527171,668144,446202,675228,444193,117204,217251,935224,597315,170
       Short-term Investments 
0
0
19,188
1,000
1,802
3,064
4,701
25,519
7,790
7,941
16,525
9,986
5,472
7,907
51,062
13,000
12,923
9,742
8,760
27,826
57,232
280,194
150,421
150,421280,19457,23227,8268,7609,74212,92313,00051,0627,9075,4729,98616,5257,9417,79025,5194,7013,0641,8021,00019,18800
       Net Receivables 
71,040
83,517
84,774
120,905
146,496
159,448
188,767
214,273
213,187
171,226
196,069
127,559
146,777
175,413
159,140
199,976
338,506
577,211
567,014
662,953
145,720
172,906
195,973
195,973172,906145,720662,953567,014577,211338,506199,976159,140175,413146,777127,559196,069171,226213,187214,273188,767159,448146,496120,90584,77483,51771,040
       Other Current Assets 
8,195
22,784
7,908
9,601
20,940
20,192
24,073
26,856
35,967
12,501
23,522
21,669
29,850
52,258
16,763
18,211
27,905
29,552
55,204
35,312
37,982
39,866
131,851
131,85139,86637,98235,31255,20429,55227,90518,21116,76352,25829,85021,66923,52212,50135,96726,85624,07320,19220,9409,6017,90822,7848,195
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,418,688
1,690,585
1,515,156
1,561,417
1,541,216
1,661,850
1,835,990
1,835,9901,661,8501,541,2161,561,4171,515,1561,690,5851,418,6880000000000000000
       Property Plant Equipment 
70,958
96,696
145,487
165,488
198,816
242,104
244,633
253,756
270,209
307,607
322,779
367,542
440,007
558,120
475,265
533,750
670,051
807,302
780,108
766,039
730,031
732,925
706,764
706,764732,925730,031766,039780,108807,302670,051533,750475,265558,120440,007367,542322,779307,607270,209253,756244,633242,104198,816165,488145,48796,69670,958
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,054
8,054
500
500
500
500
0
0
0
0005005005005008,0548,05400000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
811,079
367,246
413,339
278,143
0
0
0
0
0000278,143413,339367,246811,079000000000000000
       Intangible Assets 
13,601
11,801
11,986
47,230
51,357
16,631
18,123
12,262
14,025
9,114
7,104
8,176
26,919
22,754
123,898
110,275
182,451
319,411
309,968
302,760
282,852
286,353
241,868
241,868286,353282,852302,760309,968319,411182,451110,275123,89822,75426,9198,1767,1049,11414,02512,26218,12316,63151,35747,23011,98611,80113,601
       Other Assets 
0
75
4,507
12,104
15,298
12,203
15,549
100,856
64,024
151,981
201,318
155,492
152,818
89,759
289,431
405,730
248,329
203,717
205,093
218,934
226,392
327,278
0
0327,278226,392218,934205,093203,717248,329405,730289,43189,759152,818155,492201,318151,98164,024100,85615,54912,20315,29812,1044,507750
> Total Liabilities 
106,330
158,587
281,003
289,647
359,359
392,439
392,027
363,307
418,548
378,516
489,246
524,018
597,356
663,237
913,700
1,087,925
869,350
1,103,518
1,015,484
1,095,331
1,135,602
1,506,512
1,785,917
1,785,9171,506,5121,135,6021,095,3311,015,4841,103,518869,3501,087,925913,700663,237597,356524,018489,246378,516418,548363,307392,027392,439359,359289,647281,003158,587106,330
   > Total Current Liabilities 
64,734
85,502
196,626
178,195
251,868
256,959
376,259
330,791
412,419
347,374
391,612
427,248
486,850
573,166
758,835
888,043
756,718
1,009,243
942,622
1,013,791
1,066,257
1,437,648
1,711,948
1,711,9481,437,6481,066,2571,013,791942,6221,009,243756,718888,043758,835573,166486,850427,248391,612347,374412,419330,791376,259256,959251,868178,195196,62685,50264,734
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,500
204,500
285,000
200,500
0
0
0
0
0000200,500285,000204,50021,500000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,500
204,500
285,000
200,500
135,000
20,000
126,338
93,811
93,811126,33820,000135,000200,500285,000204,50021,500000000000000000
       Accounts payable 
13,634
16,661
34,787
20,416
40,482
80,622
43,401
34,257
28,911
27,347
27,432
44,670
33,685
40,267
54,478
59,369
61,532
85,422
61,784
67,660
78,809
78,011
68,021
68,02178,01178,80967,66061,78485,42261,53259,36954,47840,26733,68544,67027,43227,34728,91134,25743,40180,62240,48220,41634,78716,66113,634
       Other Current Liabilities 
21,100
35,841
54,839
29,979
55,886
47,437
58,058
71,034
87,108
106,627
121,680
104,078
112,165
187,399
240,357
249,541
247,776
231,875
208,481
249,280
293,191
485,271
50,834
50,834485,271293,191249,280208,481231,875247,776249,541240,357187,399112,165104,078121,680106,62787,10871,03458,05847,43755,88629,97954,83935,84121,100
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
112,632
94,274
72,862
81,541
69,345
68,864
73,968
73,96868,86469,34581,54172,86294,274112,6320000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-21,500
-204,500
-285,000
-200,500
0
8,463
7,904
6,197
6,1977,9048,4630-200,500-285,000-204,500-21,500000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,000
0
0
0
0
0
0
00000020,0000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
99,773
82,621
86,252
94,811
98,045
87,150
65,533
0
065,53387,15098,04594,81186,25282,62199,773000000000000000
> Total Stockholder Equity
408,464
401,790
414,873
432,011
440,063
453,511
456,188
559,979
529,892
627,134
691,354
665,604
679,255
967,308
1,543,478
1,725,460
2,087,072
2,174,308
2,082,131
2,209,888
2,312,724
2,278,990
2,550,919
2,550,9192,278,9902,312,7242,209,8882,082,1312,174,3082,087,0721,725,4601,543,478967,308679,255665,604691,354627,134529,892559,979456,188453,511440,063432,011414,873401,790408,464
   Common Stock
100,360
100,360
100,360
100,360
100,360
100,360
100,360
200,720
200,720
200,720
200,720
200,720
200,720
357,267
535,563
535,482
592,321
592,321
586,449
567,809
567,809
567,759
0
0567,759567,809567,809586,449592,321592,321535,482535,563357,267200,720200,720200,720200,720200,720200,720100,360100,360100,360100,360100,360100,360100,360
   Retained Earnings 
22,145
13,461
24,483
36,532
41,540
52,218
57,208
118,758
116,685
143,399
177,878
194,461
201,943
274,185
349,532
438,211
695,135
823,399
977,814
1,185,270
1,340,416
1,481,315
1,380,683
1,380,6831,481,3151,340,4161,185,270977,814823,399695,135438,211349,532274,185201,943194,461177,878143,399116,685118,75857,20852,21841,54036,53224,48313,46122,145
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
584,168
234,322
193,243
82,061
130,729
84,867
56,083
0
056,08384,867130,72982,061193,243234,322584,168000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,231,619
Cost of Revenue-858,841
Gross Profit2,372,7782,372,778
 
Operating Income (+$)
Gross Profit2,372,778
Operating Expense-2,677,127
Operating Income554,491-304,349
 
Operating Expense (+$)
Research Development123,330
Selling General Administrative1,543,450
Selling And Marketing Expenses-
Operating Expense2,677,1271,666,780
 
Net Interest Income (+$)
Interest Income23,584
Interest Expense-2,807
Other Finance Cost-13,423
Net Interest Income34,200
 
Pretax Income (+$)
Operating Income554,491
Net Interest Income34,200
Other Non-Operating Income Expenses-
Income Before Tax (EBT)598,210554,491
EBIT - interestExpense = -2,807
526,168
528,975
Interest Expense2,807
Earnings Before Interest and Taxes (EBIT)-601,017
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax598,210
Tax Provision-72,108
Net Income From Continuing Ops526,102526,102
Net Income526,168
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--34,200
 

Technical Analysis of Lingrui
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lingrui. The general trend of Lingrui is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lingrui's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Henan Lingrui Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 21.73 > 21.65 > 20.53.

Tweet this
Henan Lingrui Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Henan Lingrui Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Henan Lingrui Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Henan Lingrui Pharmaceutical Co Ltd. The current macd is 0.93471064.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Lingrui price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Lingrui. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Lingrui price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Henan Lingrui Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHenan Lingrui Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Henan Lingrui Pharmaceutical Co Ltd. The current adx is 40.61.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Lingrui shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Henan Lingrui Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Henan Lingrui Pharmaceutical Co Ltd. The current sar is 22.77.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Henan Lingrui Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Henan Lingrui Pharmaceutical Co Ltd. The current rsi is 74.33. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Henan Lingrui Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartHenan Lingrui Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Henan Lingrui Pharmaceutical Co Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Lingrui price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Henan Lingrui Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartHenan Lingrui Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Henan Lingrui Pharmaceutical Co Ltd. The current cci is 167.21.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Henan Lingrui Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartHenan Lingrui Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Henan Lingrui Pharmaceutical Co Ltd. The current cmo is 54.11.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Henan Lingrui Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartHenan Lingrui Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Henan Lingrui Pharmaceutical Co Ltd. The current willr is -6.25.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Henan Lingrui Pharmaceutical Co Ltd Daily Williams %R ChartHenan Lingrui Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Henan Lingrui Pharmaceutical Co Ltd.

Henan Lingrui Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Henan Lingrui Pharmaceutical Co Ltd. The current atr is 0.88863481.

Henan Lingrui Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartHenan Lingrui Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Henan Lingrui Pharmaceutical Co Ltd. The current obv is 428,039,579.

Henan Lingrui Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartHenan Lingrui Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Henan Lingrui Pharmaceutical Co Ltd. The current mfi is 80.55.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Henan Lingrui Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartHenan Lingrui Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Henan Lingrui Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-22BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

Henan Lingrui Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Henan Lingrui Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5074.325
Ma 20Greater thanMa 5022.415
Ma 50Greater thanMa 10021.126
Ma 100Greater thanMa 20019.110
OpenGreater thanClose24.450
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Lingrui with someone you think should read this too:
  • Are you bullish or bearish on Lingrui? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lingrui? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Henan Lingrui Pharmaceutical Co Ltd

I send you an email if I find something interesting about Henan Lingrui Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Henan Lingrui Pharmaceutical Co Ltd.

Receive notifications about Henan Lingrui Pharmaceutical Co Ltd in your mailbox!